Europe's drugs regulator is looking into possible links between weight-loss jabs and thoughts of suicide and self-harm
Weight reduction drugs including Wegovy and Saxenda are being reviewed by Europe’s drugs regulator over a possible connection to thoughts of suicide and self-harm amongst users. Ozempic, which is approved as diabetes medication but often used off-label for weight reduction as a consequence of its appetite curbing side-effects, can also be being included within the review.
The European Medicines Agency was alerted to the potential link by Iceland following three cases, the BBC reports. Because of this, the regulator’s Pharmacovigilance Risk Assessment Committee will investigate medication that accommodates either semaglutide or liraglutide. It should also consider whether...
Continue reading
0 Comments